Patents by Inventor Sylesh Kumar Venkataraman

Sylesh Kumar Venkataraman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Acid-Labile Lipophilic Prodrugs of Cancer Chemotherapeutic Agents
    Publication number: 20190117784
    Abstract: The present application discloses an acid labile lipophilic molecular conjugate of cancer chemotherapeutic agents and methods for reducing or substantially eliminating the side effects of chemotherapy associated with the administration of a cancer chemotherapeutic agent to a patient in need thereof.
    Type: Application
    Filed: November 13, 2018
    Publication date: April 25, 2019
    Inventors: James D. McChesney, John T. Henri, Sylesh Kumar Venkataraman, Mahesh Kumar Gundluru
  • Acid-labile lipophilic prodrugs of cancer chemotherapeutic agents
    Patent number: 10172957
    Abstract: The present application discloses an acid labile lipophilic molecular conjugate of cancer chemotherapeutic agents and methods for reducing or substantially eliminating the side effects of chemotherapy associated with the administration of a cancer chemotherapeutic agent to a patient in need thereof.
    Type: Grant
    Filed: August 11, 2017
    Date of Patent: January 8, 2019
    Assignee: Veiled Therapeutics, LLC
    Inventors: James D. McChesney, John T. Henri, Sylesh Kumar Venkataraman, Mahesh Kumar Gundluru
  • Acid-Labile Lipophilic Prodrugs of Cancer Chemotherapeutic Agents
    Publication number: 20180161439
    Abstract: The present application discloses an acid labile lipophilic molecular conjugate of cancer chemotherapeutic agents and methods for reducing or substantially eliminating the side effects of chemotherapy associated with the administration of a cancer chemotherapeutic agent to a patient in need thereof.
    Type: Application
    Filed: August 11, 2017
    Publication date: June 14, 2018
    Inventors: James D. McChesney, John T. Henri, Sylesh Kumar Venkataraman, Mahesh Kumar Gundluru
  • Acid-labile lipophilic prodrugs of cancer chemotherapeutic agents
    Patent number: 9889201
    Abstract: The present application discloses an acid labile lipophilic molecular conjugate of cancer chemotherapeutic agents and methods for reducing or substantially eliminating the side effects of chemotherapy associated with the administration of a cancer chemotherapeutic agent to a patient in need thereof.
    Type: Grant
    Filed: April 18, 2016
    Date of Patent: February 13, 2018
    Assignee: ARBOR THERAPEUTICS, LLC
    Inventors: James D. McChesney, John T. Henri, Sylesh Kumar Venkataraman, Mahesh Kumar Gundluru
  • Acid-Labile Lipophilic Prodrugs of Cancer Chemotherapeutic Agents
    Publication number: 20160354475
    Abstract: The present application discloses an acid labile lipophilic molecular conjugate of cancer chemotherapeutic agents and methods for reducing or substantially eliminating the side effects of chemotherapy associated with the administration of a cancer chemotherapeutic agent to a patient in need thereof.
    Type: Application
    Filed: April 18, 2016
    Publication date: December 8, 2016
    Inventors: James D. McChesney, John T. Henri, Sylesh Kumar Venkataraman, Mahesh Kumar Gundluru
  • Acid-labile lipophilic prodrugs of cancer chemotherapeutic agents
    Patent number: 9339555
    Abstract: The present application discloses an acid labile lipophilic molecular conjugate of cancer chemotherapeutic agents and methods for reducing or substantially eliminating the side effects of chemotherapy associated with the administration of a cancer chemotherapeutic agent to a patient in need thereof.
    Type: Grant
    Filed: March 17, 2014
    Date of Patent: May 17, 2016
    Assignee: ARBOR THERAPEUTICS, LLC
    Inventors: James D. McChesney, John T. Henri, Sylesh Kumar Venkataraman, Mahesh Kumar Gundluru
  • Acid-Labile Lipophilic Prodrugs of Cancer Chemotherapeutic Agents
    Publication number: 20140249213
    Abstract: The present application discloses an acid labile lipophilic molecular conjugate of cancer chemotherapeutic agents and methods for reducing or substantially eliminating the side effects of chemotherapy associated with the administration of a cancer chemotherapeutic agent to a patient in need thereof.
    Type: Application
    Filed: March 17, 2014
    Publication date: September 4, 2014
    Applicant: ARBOR THERAPEUTICS, LLC
    Inventors: James D. McChesney, John T. Henri, Sylesh Kumar Venkataraman, Mahesh Kumar Gundluru
  • Acid-labile lipophilic prodrugs of cancer chemotherapeutic agents
    Patent number: 8716328
    Abstract: The present application discloses an acid labile lipophilic molecular conjugate of cancer chemotherapeutic agents and methods for reducing or substantially eliminating the side effects of chemotherapy associated with the administration of a cancer chemotherapeutic agent to a patient in need thereof.
    Type: Grant
    Filed: April 3, 2013
    Date of Patent: May 6, 2014
    Inventors: James D. McChesney, John T. Henri, Sylesh Kumar Venkataraman, Mahesh Kumar Gundluru
  • Acid-Labile Lipophilic Prodrugs of Cancer Chemotherapeutic Agents
    Publication number: 20130303601
    Abstract: The present application discloses an acid labile lipophilic molecular conjugate of cancer chemotherapeutic agents and methods for reducing or substantially eliminating the side effects of chemotherapy associated with the administration of a cancer chemotherapeutic agent to a patient in need thereof.
    Type: Application
    Filed: April 3, 2013
    Publication date: November 14, 2013
    Inventors: James D. McChesney, John T. Henri, Sylesh Kumar Venkataraman, Mahesh Kumar Gundluru
  • Acid-labile lipophilic prodrugs of cancer chemotherapeutic agents
    Patent number: 8440714
    Abstract: The present application discloses an acid labile lipophilic molecular conjugate of cancer chemotherapeutic agents and methods for reducing or substantially eliminating the side effects of chemotherapy associated with the administration of a cancer chemotherapeutic agent to a patient in need thereof.
    Type: Grant
    Filed: June 5, 2012
    Date of Patent: May 14, 2013
    Assignee: Arbor Therapeutics, LLC
    Inventors: James D. McChesney, John T. Henri, Sylesh Kumar Venkataraman, Mahesh Kumar Gundluru
  • Acid-Labile Lipophilic Prodrugs of Cancer Chemotherapeutic Agents
    Publication number: 20120309819
    Abstract: The present application discloses an acid labile lipophilic molecular conjugate of cancer chemotherapeutic agents and methods for reducing or substantially eliminating the side effects of chemotherapy associated with the administration of a cancer chemotherapeutic agent to a patient in need thereof.
    Type: Application
    Filed: June 5, 2012
    Publication date: December 6, 2012
    Inventors: James D. McChesney, John T. Henri, Sylesh Kumar Venkataraman, Mahesh Kumar Gundluru